The Effect of Various Interventions on the Prevention of Radiation Dermatitis: a Network Meta-analysis

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2024 Jun 17

PMID 38883361

Authors

Hongxin Cao

Wangbin Li

Hongyi Cai

Affiliations

Soon will be listed here.

Abstract

Objective: High doses of radiation, while effective at destroying tumor tissues, also result in radiation dermatitis (RD) at irradiated sites, which is one of the most common complications in cancer radiotherapy. Currently, no standardized protocols for the prevention and treatment of RD have been established in clinical practices, and severe RD can compromise treatment efficacy and reduce patients' quality of life. This systematic review and network meta-analysis (NMA) aims to compare the effectiveness of various interventions in preventing RD in patients.

Methods: As of June 2023, four databases, including PubMed, Embase, Web of Science, and the Cochrane Library, were searched, with a total of 19 interventions obtained for comparative analysis of their effectiveness in preventing RD. The Cochrane risk-of-bias tool was employed to screen literature, extract data, and appraise the quality of the studies by two researchers. Bayesian network meta-analysis (NMA) was conducted utilizing StataSE 15 and R 4.2.3.

Results: A total of 33 studies involving 4307 patients were included in this analysis. From the 33 studies, 19 interventions, encompassing Barrier Films and Dressings (BFD), Boron_Gel, Best supportive care, Corticosteroids_cream, Doxepin_cream, Eau Thermale Avèn_gel, Epidermal Growth Factor_cream, Hyaluronan_cream, Medicinal_Plants, Mineral_Oil, Olive oil and calcium hydroxide (OOCH), Photobiomodulation therapy, Recove_cream, Silicone_gel, Silver sulfadiazine (SSD), Timolol_Gel, Trolamine, VitD_Gel, and VitE_Gel, were retrieved and compared. The NMA results indicated that Hyaluronan_cream (SUCRA: 94.9%) was highly effective in preventing Grade 0/1 RD. Meanwhile, OOCH (SUCRA: 95.7%) demonstrated the most prominent effect in preventing ≥ Grade 2 RD.

Conclusion: The study reveals that Hyaluronan_cream and OOCH are two promising treatments for the prevention of RD in patients undergoing radiotherapy. Future research might focus on validating the efficacy of these two therapies with large sample sizes and on identifying an optimal intervention strategy.

References

Kong M, Hong S . Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study. Asian Pac J Cancer Prev. 2013; 14(8):4859-64. DOI: 10.7314/apjcp.2013.14.8.4859. View

Cox J, Stetz J, Pajak T . Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31(5):1341-6. DOI: 10.1016/0360-3016(95)00060-C. View

Hindley A, Zain Z, Wood L, Whitehead A, Sanneh A, Barber D . Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys. 2015; 90(4):748-55. DOI: 10.1016/j.ijrobp.2014.06.033. View

Zhang X, Li H, Li Q, Li Y, Li C, Zhu M . Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer. World J Surg Oncol. 2018; 16(1):222. PMC: 6233368. DOI: 10.1186/s12957-018-1522-3. View

Wilson B, Shah R, Menzer C, Aleisa A, Sun M, Kwong B . Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey. Br J Dermatol. 2022; 187(6):1054-1056. PMC: 10087782. DOI: 10.1111/bjd.21852. View

Nabi-Meybodi M, Sahebnasagh A, Hakimi Z, Shabani M, Shakeri A, Saghafi F . Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial. BMC Cancer. 2022; 22(1):1079. PMC: 9583052. DOI: 10.1186/s12885-022-10064-x. View

Behroozian T, Milton L, Karam I, Zhang L, Ding K, Lou J . Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial. J Clin Oncol. 2022; 41(6):1250-1264. DOI: 10.1200/JCO.22.01873. View

Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H . Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis. Front Oncol. 2021; 11:738851. PMC: 8667470. DOI: 10.3389/fonc.2021.738851. View

Shariati L, Amouheidari A, Naji Esfahani H, Abed A, Javanmard S, Laher I . Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial. Br J Clin Pharmacol. 2020; 86(9):1875-1881. PMC: 7444764. DOI: 10.1111/bcp.14238. View

10.

Salminen A, Kaarniranta K, Kauppinen A . Photoaging: UV radiation-induced inflammation and immunosuppression accelerate the aging process in the skin. Inflamm Res. 2022; 71(7-8):817-831. PMC: 9307547. DOI: 10.1007/s00011-022-01598-8. View

11.

Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F . Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci. 2015; 19(8):1338-44. View

12.

Ma L, Chen Y, Gong Q, Cheng Z, Ran C, Liu K . Cold atmospheric plasma alleviates radiation-induced skin injury by suppressing inflammation and promoting repair. Free Radic Biol Med. 2023; 204:184-194. DOI: 10.1016/j.freeradbiomed.2023.05.002. View

13.

Pommier P, Gomez F, Sunyach M, DHombres A, Carrie C, Montbarbon X . Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004; 22(8):1447-53. DOI: 10.1200/JCO.2004.07.063. View

14.

Nasser N, Fenig S, Ravid A, Nouriel A, Ozery N, Gardyn S . Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients. NPJ Breast Cancer. 2017; 3:10. PMC: 5460188. DOI: 10.1038/s41523-017-0006-x. View

15.

Pinnix C, Perkins G, Strom E, Tereffe W, Woodward W, Oh J . Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys. 2011; 83(4):1089-94. PMC: 3935608. DOI: 10.1016/j.ijrobp.2011.09.021. View

16.

Liao Y, Feng G, Dai T, Long F, Tang J, Pu Y . Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas. Medicine (Baltimore). 2019; 98(52):e18230. PMC: 6946454. DOI: 10.1097/MD.0000000000018230. View

17.

Chan R, Blades R, Jones L, Downer T, Peet S, Button E . A single-blind, randomised controlled trial of StrataXRT® - A silicone-based film-forming gel dressing for prophylaxis and management of radiation dermatitis in patients with head and neck cancer. Radiother Oncol. 2019; 139:72-78. DOI: 10.1016/j.radonc.2019.07.014. View

18.

Fife D, Rayhan D, Behnam S, Ortiz A, Elkeeb L, Aquino L . A randomized, controlled, double-blind study of light emitting diode photomodulation for the prevention of radiation dermatitis in patients with breast cancer. Dermatol Surg. 2010; 36(12):1921-7. DOI: 10.1111/j.1524-4725.2010.01801.x. View

19.

Wooding H, Yan J, Yuan L, Chyou T, Gao S, Ward I . The effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer patients: a feasibility study. Br J Radiol. 2017; 91(1081):20170298. PMC: 5966207. DOI: 10.1259/bjr.20170298. View

20.

de Meneses A, Reis P, Guerra E, De Luca Canto G, Ferreira E . Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis. Rev Lat Am Enfermagem. 2018; 26:e2929. PMC: 5942864. DOI: 10.1590/1518-8345.2035.2929. View